Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 140 citing articles:

The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Aleksandra Deczkowska, Assaf Weiner, Ido Amit
Cell (2020) Vol. 181, Iss. 6, pp. 1207-1217
Open Access | Times Cited: 420
Microglia regulation of synaptic plasticity and learning and memory
Miou Zhou, Jessica Cornell, Shelbi Salinas, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 4, pp. 705-705
Open Access | Times Cited: 301
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
Seung-Hye Lee, William J. Meilandt, Luke Xie, et al.
Neuron (2021) Vol. 109, Iss. 8, pp. 1283-1301.e6
Open Access | Times Cited: 185
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Joseph W. Lewcock, Kai Schlepckow, Gilbert Di Paolo, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 801-821
Open Access | Times Cited: 179
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 162
Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models
Borislav Dejanovic, Tiffany Wu, Ming‐Chi Tsai, et al.
Nature Aging (2022) Vol. 2, Iss. 9, pp. 837-850
Open Access | Times Cited: 158
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Alanna G. Spiteri, Claire L. Wishart, Roger Pamphlett, et al.
Acta Neuropathologica (2021) Vol. 143, Iss. 2, pp. 179-224
Open Access | Times Cited: 148
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Bettina van Lengerich, Lihong Zhan, Dan Xia, et al.
Nature Neuroscience (2023)
Open Access | Times Cited: 134
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
Estrella Morenas‐Rodríguez, Yan Li, Brigitte Nuscher, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 4, pp. 329-341
Open Access | Times Cited: 123
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Jifei Miao, Haixia Ma, Yang Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 93
TREM2 dependent and independent functions of microglia in Alzheimer’s disease
Jinchao Hou, Yun Chen, Gary E. Grajales‐Reyes, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 92
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine
Marina A. Lynch
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 89
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 81
Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model
Qian Shi, Cheng Chang, Afaf Saliba, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 27, pp. 5294-5313
Open Access | Times Cited: 75
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease
Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 661
Closed Access | Times Cited: 73
TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
Yueran Li, Huifang Xu, Huifang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115218-115218
Open Access | Times Cited: 47
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 45
Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains
Andrew M. Stern, Yang Yang, Shan‐Xue Jin, et al.
Neuron (2023) Vol. 111, Iss. 13, pp. 2012-2020.e4
Open Access | Times Cited: 44
Passive immunotherapy for Alzheimer's disease
Xiaoyi Guo, Yan Li, Denghong Zhang, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102192-102192
Open Access | Times Cited: 26
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease
Rosemary J. Jackson, Megan S. Keiser, Jonah C Meltzer, et al.
Molecular Therapy (2024) Vol. 32, Iss. 5, pp. 1373-1386
Open Access | Times Cited: 26
Microglia and amyloid plaque formation in Alzheimer's disease – Evidence, possible mechanisms, and future challenges
Stefanie Fruhwürth, Henrik Zetterberg, Søren R. Paludan
Journal of Neuroimmunology (2024) Vol. 390, pp. 578342-578342
Open Access | Times Cited: 21
Bacteroidota inhibit microglia clearance of amyloid-beta and promote plaque deposition in Alzheimer’s disease mouse models
Caroline Wasén, Leah C. Beauchamp, Julia Vincentini, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions
Wenfei Liu, Orjona Taso, Rui Wang, et al.
Human Molecular Genetics (2020) Vol. 29, Iss. 19, pp. 3224-3248
Open Access | Times Cited: 124
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
Michael Ewers, Gloria Biechele, Marc Suárez‐Calvet, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 9
Open Access | Times Cited: 104
Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia
Hemraj B. Dodiya, Holly L. Lutz, Ian Q. Weigle, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 1
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top